Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Erin B. Bailey"'
Autor:
Nazli Dizman, Ameish Govindarajan, Zeynep Busra Zengin, Luis A Meza, Nishita Tripathi, Nicolas Sayegh, Daniela V. Castro, Elyse H. Chan, Kyle O. Lee, Sweta R. Prajapati, Matthew I. Feng, Vivian Loo, Makala Pace, Shea O'brien, Erin B. Bailey, Regina Barragan-Carrillo, Alex Chehrazi-Raffle, Xiaochen Li, Neeraj Agarwal, Sumanta Monty Pal
Publikováno v:
Journal of Clinical Oncology. 41:678-678
678 Background: Recent studies have suggested an association between the time-of-day of ICI infusions and disease outcomes, including progression free survival and overall survival, among patients with cancer. (Qian et al Lancet Oncology 2021). We so
Autor:
David Gill, Lubina Arjyal, Sumanta K. Pal, Andrew W. Hahn, Neeraj Agarwal, Sumati Gupta, Benjamin L. Maughan, Erin B. Bailey, Jessica Streeter, Archana M. Agarwal
Publikováno v:
Oncotarget
// Andrew W. Hahn 1 , David M. Gill 1 , Benjamin Maughan 2 , Archana Agarwal 3 , Lubina Arjyal 2 , Sumati Gupta 2 , Jessica Streeter 4 , Erin Bailey 4 , Sumanta K. Pal 5 , Neeraj Agarwal 2 1 Department of Internal Medicine, University of Utah, Salt L
Autor:
Srinivas K. Tantravahi, David D. Stenehjem, Sumanta K. Pal, Austin Poole, Shiven B. Patel, Archana M. Agarwal, Joseph Merriman, Julia A. Batten, Erin B. Bailey, Neeraj Agarwal, Benjamin L. Maughan
Publikováno v:
Journal of Oncology Pharmacy Practice. 24:190-197
Purpose Hand-foot syndrome is a common dose limiting toxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors used for treatment of patients with metastatic renal cell carcinoma. The effect of treatment dose reductions, in t
Autor:
Benjamin L. Maughan, Erin B. Bailey, Andrew W. Hahn, Roberto Nussenzveig, Julia A. Batten, David D. Stenehjem, Emma Carroll, Neeraj Agarwal
Publikováno v:
Cancer treatment and research communications. 19
Background Targeted therapies have shown promise for men with metastatic castration-resistant prostate cancer (mCRPC). Due to the difficulty with obtaining tumor tissue in bony metastases, liquid biopsies are a promising alternative to guide treatmen
Autor:
Neeraj Agarwal, Sunil Sharma, Hanna Bailey, Guru Reddy, Erin B. Bailey, Sumati Gupta, Gajanan Bhat, Jordan P. McPherson, Theresa L. Werner
Publikováno v:
Cancer Chemotherapy and Pharmacology. 77:299-308
Belinostat is a potent small molecule inhibitor that exerts its antitumor effect through inhibition of histone deacetylase. The purpose of this study was to evaluate the pharmacokinetics and pharmacodynamics of warfarin (as a reference drug metaboliz
Autor:
David D. Stenehjem, Erin B. Bailey, Andrew W. Hahn, Camryn Froerer, Nityam Rathi, Neeraj Agarwal, Sidney VanAlstine
Publikováno v:
Clinical genitourinary cancer. 16(5)
Background Vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs) are a mainstay of treatment for metastatic renal-cell carcinoma. Stool microbiome composition is predictive of response to immunotherapy and cytotoxic chemotherapy
Autor:
Erin B. Bailey, Austin Poole, Neeraj Agarwal, David D. Stenehjem, Julia A. Batten, Chesley E. Wells, Archana M. Agarwal, Alli M. Straubhar, Srinivas K. Tantravahi, Shiven B. Patel
Publikováno v:
Clinical Genitourinary Cancer. 13:e131-e137
Background Hypothyroidism is a common adverse effect of vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapy in patients with metastatic renal cell carcinoma (mRCC). Some studies have shown an association with imp
Publikováno v:
Frontiers in Oncology
Program death receptor-1 (PD-1) and program death receptor-1 ligand (PD-L1) inhibitors are increasingly being used in the clinic to treat a growing number of malignancies, including many genitourinary malignancies. These immune based therapies have d
Autor:
Neeraj Agarwal, Julia A. Batten, David D. Stenehjem, Kenneth M. Boucher, Anitha Alex, Sumati Gupta, David C. Gaston, Andrew W. Hahn, Erin B. Bailey, David Gill
Publikováno v:
Clinical genitourinary cancer. 15(4)
Background Abiraterone acetate has been approved for metastatic castration-resistant prostate cancer (mCRPC). Coadministration with prednisone has been recommended to prevent the toxicity from secondary mineralocorticoid excess, such as hypertension,
Autor:
Jessica Campaign Mauser, Erin B. Bailey, Neeraj Agarwal, Benjamin L. Maughan, Sumati Gupta, Cassia R Griswold, Kenneth M. Boucher
Publikováno v:
Journal of Clinical Oncology. 37:520-520
520 Background: The Khorana score is the primary tool utilized to predict VTE risk in patients with cancer. This score incorporates primary cancer site, pretreatment hematologic parameters, and body mass index. GCT are considered high-risk for VTE. H